Collaboration Details

Title of Collaborative Activity:

Memorandum of Understanding (MOU) between the FDA/Center for Drug Evaluation and Research (FDA/CDER) and NIH/NINDS

Description of Collaborative Activity:

This Memorandum of Understanding (MOU) provides a mechanism for addressing cross-cutting issues related to drug therapy development for neurological disorders, from bench science to clinical trials and the Food and Drug Administration (FDA) approval and licensure.

Type of Collaborative Activity:

Other

Year the Collaborative Activity Originated:

2019

NIH Participating Institutes/Centers/Office of the Director:

NINDS

HHS Agency Collaborators on this Activity:

FDA